Biotech companies by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 24 biotech companies ranked by short interest, at 19.2%, ahead of CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Scholar Rock Holding19.2%
Median
9.33%
Combined market value
CHF 705.3B
Countries
5

Market values as of .

All countries
All sectors
Biotech
CHF
Clear filters
Biotech companies by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%CHF 4.9BCHF 40.09 5.37% up 14% up United States
2CRISPR TherapeuticsCRSP · Health Care17.7%CHF 3.4BCHF 34.56 1.99% up 21% down Switzerland
3Twist BioscienceTWST · Health Care14.4%CHF 6.8BCHF 99.85 5.63% up 340% up United States
4Kodiak SciencesKOD · Health Care12.4%CHF 5.3BCHF 81.59 0.13% down 396% up United States
5Halozyme TherapeuticsHALO · Health Care12.0%CHF 9.3BCHF 81.14 0.18% up 37% up United States
6ImmunityBioIBRX · Health Care11.9%CHF 6BCHF 5.68 7.51% up 193% up United States
7RepligenRGEN · Health Care11.0%CHF 9.2BCHF 144.34 5.46% up 5% up United States
8ExelixisEXEL · Health Care10.5%CHF 14.1BCHF 57.83 0.04% up 63% up United States
9CG OncologyCGON · Health Care10.3%CHF 6BCHF 66.94 0.47% up 85% up United States
10Krystal BiotechKRYS · Health Care10.3%CHF 7.8BCHF 264.27 4.88% up 46% up United States
11Kymera TherapeuticsKYMR · Health Care9.84%CHF 8.7BCHF 102.35 0.20% down 87% up United States
12VaxcytePCVX · Health Care9.70%CHF 7.8BCHF 49.20 1.85% down 22% up United States
13ImmunovantIMVT · Health Care8.96%CHF 5.8BCHF 28.06 0.12% up 43% up United States
14ModernaMRNA · Health Care8.20%CHF 67.7BCHF 167.34 4.12% down 755% up United States
15Adaptive BiotechnologiesADPT · Health Care7.09%CHF 3.9BCHF 24.04 0.04% down 88% up United States
16Revolution MedicinesRVMD · Health Care6.05%CHF 29.3BCHF 135.33 1.44% down 131% up United States
17Neurocrine BiosciencesNBIX · Health Care5.83%CHF 13.9BCHF 137.79 1.60% down 20% up United States
18Bio-TechneTECH · Health Care4.90%CHF 9.6BCHF 61.42 0.21% up 26% up United States
19BiogenBIIB · Health Care3.69%CHF 31.2BCHF 211.05 0.29% down 49% up United States
20QiagenQGEN · Health Care3.10%CHF 8.6BCHF 41.87 0.27% down 12% up Netherlands
21AmgenAMGN · Health Care2.33%CHF 202.1BCHF 373.66 3.32% down 34% up United States
22argenxARGX · Health Care2.25%CHF 50.1BCHF 796.02 0.46% down 4% up Belgium
23Gilead SciencesGILD · Health Care1.72%CHF 176.2BCHF 142.07 1.13% down 33% up United States
24BioNTechBNTX · Health Care0.91%CHF 17.5BCHF 70.44 1.65% down 16% down Germany

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8440 CHF).

Questions and answers

Which biotech companies rank first by short interest?

Scholar Rock Holding (19.2%), CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%) are the top three of the 24 biotech companies ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech companies are in this ranking?

24 are ranked by short interest.

What are these biotech companies worth together?

The 24 biotech companies ranked by short interest have a combined market value of CHF 705.3B as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.